Interact to see
Advertisement
Advertisement
CEBRX vs MEDFX
CEBRX vs MEDFX Comparison
Open Charts CEBRX vs MEDFX
Columbia Emerging Markets Bond Inst2
Price$10.11
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets347.19M
MFS Emerging Markets Debt R3
Price$12.65
Change+$0.01 (+0.08%)
VolumeN/A
Net Assets7.63B
CEBRX vs MEDFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
CEBRX vs. MEDFX commentary
Nov 20, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CEBRX is a Hold and MEDFX is a Hold.
FUNDAMENTALS
Fundamentals
MEDFX has more cash in the bank: 7.63B vs. CEBRX (347M). CEBRX (5.13) and MEDFX (5.09) have matching dividends . CEBRX was incepted earlier than MEDFX: CEBRX (13 years) vs MEDFX (17 years). MEDFX (1.07) is less costly to investors than CEBRX (0.75). CEBRX (0) and MEDFX (0) have matching initial minimum investment requirements. CEBRX annual gain was more profitable for investors over the last year : 11.46 vs. MEDFX (10.52). CEBRX (10.84) and MEDFX (10.44) have equivalent 5 years return.
| CEBRX | MEDFX | CEBRX / MEDFX | |
| Total Expense Ratio | 0.75 | 1.06 | 71% |
| Annual Report Gross Expense Ratio | 0.75 | 1.07 | 70% |
| Fund Existence | 13 years | 17 years | - |
| Gain YTD | 11.598 | 10.341 | 112% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 347M | 7.63B | 5% |
| Annual Yield % from dividends | 5.13 | 5.09 | 101% |
| Returns for 1 year | 11.46 | 10.52 | 109% |
| Returns for 3 years | 35.34 | 34.57 | 102% |
| Returns for 5 years | 10.84 | 10.44 | 104% |
| Returns for 10 years | 49.63 | 46.79 | 106% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement